Total Funding
43
57
Total FundingSeries B raised
Growth Score 43 in past quarter
-2 pts
Heat Score 57 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33103
Direct Biologics is a market leading innovator and cGMP manufacturer of regenerative biologic products, including ExoFlo.
- Mark Adams: Founder & CEO
- Joe Schmidt: Co-Founder and Member of the Board of Directors
About the Company
Direct Biologics is an incubation center that manufactures science-based regenerative biological products. As a pioneer in the market and a cGMP manufacturer of regenerative biologic products, Direct Biologics is built on science. The company is dedicated to providing the most up-to-date clinical and scientific knowledge through careful and
meticulous research.